The University of Gothenburg writes about the launch of REAL AD

The interview discusses, among other things, that the study focuses on the potential for early diagnosis based on digital cognitive tests and blood markers. If the combination of the tools works to detect early signs of disease in the general population, the hope is that they will be used in primary care in the future to follow individuals over time and identify Alzheimer's with greater certainty and much earlier than is often the case today.

Also published in Medicinsk access, Neurologi i Sverige, Akademiliv, and Sahlgrenska Liv.